1. Home
  2. MATW vs RLMD Comparison

MATW vs RLMD Comparison

Compare MATW & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$27.69

Market Cap

872.1M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$5.18

Market Cap

524.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
RLMD
Founded
1850
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
524.9M
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
MATW
RLMD
Price
$27.69
$5.18
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.40
AVG Volume (30 Days)
305.4K
2.4M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
3.67%
N/A
EPS Growth
59.07
45.28
EPS
0.69
N/A
Revenue
$1,795,737,000.00
$13,070.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$39.19
N/A
Revenue Growth
N/A
154.83
52 Week Low
$21.95
$0.55
52 Week High
$30.93
$8.00

Technical Indicators

Market Signals
Indicator
MATW
RLMD
Relative Strength Index (RSI) 56.81 34.18
Support Level $25.33 $4.06
Resistance Level $28.57 $7.28
Average True Range (ATR) 0.78 0.40
MACD 0.08 -0.11
Stochastic Oscillator 78.01 18.18

Price Performance

Historical Comparison
MATW
RLMD

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: